Abstract
A pharmaceutical or biopharmaceutical company is a commercial business licensed to research, develop, market, and/or distribute drugs, most commonly in the context of healthcare. It is subject to a variety of laws and regulations regarding the patenting, testing, and marketing of drugs, particularly prescription drugs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Readings and References
Barfield, C.E., Groombridge, M.A.: The economic case for copyright and owner control over parallel imports. J. World Intellect. Prop. 1, 903–939 (1998)
Bellman, R.: A Markovian decision process. J. Math. Mech. 6, 23–35 (1957a)
Bellman, R.: Dynamic Programming. Princeton University Press, Princeton (1957b)
Berger, J.: Statistical Decision Theory and Bayesian Analysis. Springer, New York (1985)
Bernard, S.: The drug drought, Pharmaceutical Executive, November 1 (2002). www.design-and-determination.com. Accessed 15 June 2010
Bertsekas, D.: Dynamic Programming and Optimal Control, vol. 2. Athena, Belmont (1995)
Braess, D.: Über ein Paradoxon aus der Verkehrsplanung. Unternehmensforschung 12, 258–268 (1969)
Cambridge Pharma Consultancy: Pricing and Reimbursement Review 2003. IMS Health-Management Consulting, Cambridge (2004)
Chang, M.: Biomarker development. In: Statistics for Translational Medicine. Taylor and Francis, New York (2008)
Chang, M., Chow, S.C.: Power and sample size for dose response studies. In: Ting, N. (ed.) Dose Finding in Drug Development. Springer, New York (2006)
Chang, M.: Monte Carlo Simulation for the Pharmaceutical Industry. Chapman and Hall/CRC, Boca Raton (2010)
Chard, J.S., Mellor, C.J.: Intellectual property rights and parallel imports. World Econ. 12, 69–83 (1989)
Danzon, P., Towse, A.: Differential pricing for pharmaceuticals: Reconciling access, R&D and patents. Int. J. Health Care Finance Econ. 3, 183–205 (2003)
Gosavi, A.: Simulation-based Optimization: Parametric Optimization Techniques and Reinforcement Learning. Springer, Boston (2003)
Dresher, M.: Games of Strategy. Prentice-Hall, Englewood Cliffs (1961)
Grossman, G., Lai, E.: Parallel imports and price controls. RAND J Econ. 39(2), 378–402 (2008)
Havil, J.: Impossible? Surprising Solutions to Counterintuitive Conundrums. Princeton University Press, Priceton (2008)
Hu, M., Schultz, K., Sheu, J., Tschopp, D.: The Innovation Gap in Pharmaceutical Drug Discovery & New Models for R&D Success. www.kellogg.northwestern.edu/academic/biotech/faculty/articles/NewRDModel.pdf (2007). Accessed 2 Mar 2009
McCain, R.: Strategy and Conflict: An Introductory Sketch of Game Theory. http://william-king.www.drexel.edu (2009). Accessed 20 June 2009
Nash, J.: Non-coorperative games. Ann. Math. 5, 286–295 (1951)
Parmigiani, G., Inoue, L.: Decision Theory: Principles and Approaches. Wiley, Hokoken (2009)
Pearlman, J.B.: The commercialization of medicine. http://www.google.com (2007). Accessed 10 Sep 2009
Powell, W.B.: Approximate Dynamic Programming: Solving the Curses of Dimensionality. Wiley-Interscience, New York (2007)
Watson, J.: Strategy. W.W. Norton and Company, New York (2008)
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Chang, M. (2011). Pharmaceutical Decision and Game Theory. In: Modern Issues and Methods in Biostatistics. Statistics for Biology and Health. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9842-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9842-2_2
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-9841-5
Online ISBN: 978-1-4419-9842-2
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)